Found: 111 articles

Article Edition
A.I. Kochetkov (1), A.P. Pereverzev (1), O.D. Ostroumova (1), D.G. Gusenbekova (1), R.R. Romanovsky (2), N.A. Shatalova (3)
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
№3 / 2021
N.A. Chernikova, O.A. Knyshenko, L.P. Ivanova
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
№4 / 2021
N.A. Shevkunova (1), M.V. Vorobyov (2), V.V. Gushchin (2)
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
№4 / 2021
M.B. Antsiferov (1), A.V. Zilov (2), O.M. Koteshkova (1), N.A. Demidov (3)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
№4 / 2021
A.S. Ametov (1), E.A. Tertychnaya (2)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
№14 / 2019
T.N. Markova (1, 2)
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
№4 / 2019
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
№4 / 2019
L.A. Sharonova, A.F. Verbovoy
The place of glyflozins in the management of type 2 diabetes mellitus
№4 / 2019
A.P. Pereverzev, O.D. Ostroumova, O.N. Tkacheva
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
№4 / 2019
K.V. Antonova (1), M.M. Tanashyan (1), M.Yu. Maksimova (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
№4 / 2019
G.I. Izhbuldina (1), L.B. Novikova (2)
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
№4 / 2019
M.B. Antsiferov (1), B.B. Kvasnikov (2)
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
№4 / 2019


Бионика Медиа